In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice

Diabetes

Volumn 56, Issue 10, 2007, Pages 2551-2560

  Jarchum, Irene ^a   Baker, Jason C ^a   Yamada, Tatsuya ^a   Takaki, Toshiyuki ^a   Marron, Michele P ^b   Serreze, David V ^c   DiLorenzo, Teresa P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; INSULIN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREAS ISLET CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN TARGETING; TRANSGENIC MOUSE;

ANIMALS; BETA 2-MICROGLOBULIN; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HLA-A ANTIGENS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS;

EID: 34948850833     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0332     Document Type: Article

References (50)

1. a donors. Diabetes 42:44-55, 1993
2. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss WM, Seidman JG, Eisenbarth GS: The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231:733-735, 1986
3. β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987
4. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 26:1762-1769, 1996
5. Pearson T, Markees TG, Serreze DV, Pierce MA, Marron MP, Wicker LS, Peterson LB, Shultz LD, Mordes JP, Rossini AA, Greiner DL: Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice. J Immunol 171:185-195, 2003
6. Katz J, Benoist C, Mathis D: Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 23:3358-3360, 1993
7. null mice are diabetes and insulitis resistant. Diabetes 43:505-509, 1994
8. Sumida T, Furukawa M, Sakamoto A, Namekawa T, Maeda T, Zijlstra M, Iwamoto I, Koike T, Yoshida S, Tomioka H, Taniguchi M: Prevention of insulitis and diabetes in β2-microglobulin-deficient non-obese diabetic mice. Int Immunol 6:1445-1449, 1994
9. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zijlstra M, Jaenisch R, Peterson LB: β2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500-504, 1994
10. DiLorenzo TP, Graser RT, Ono T, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV: Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement. Proc Natl Acad Sci U S A 95:12538-12543, 1998
11. Serreze DV, Chapman HD, Varnum DS, Gerling I, Leiter EH, Shultz LD: Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 158:3978-3986, 1997
12. + cytotoxic T cells in the destruction of pancreatic β-cells in nonobese diabetic mice. J Immunol 152:2042-2050, 1994
13. + T cells from nonobese diabetic mice use highly homologous T cell receptor α-chain CDR3 sequences. J Immunol 154:2494-2503, 1995
14. + T cells of non-obese diabetic mice. J Immunol 151:1723-1730, 1993
15. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr: CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76, 1996
16. Graser RT, DiLorenzo TP, Wang F, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV: Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 164:3913-3918, 2000
17. + T-cell clones in vivo. Diabetes 45:1121-1131, 1996
18. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P: Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 186:1663-1676, 1997
19. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353-360, 1985
20. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, Kawata S, Tarui S, Kono N, Matsuzawa Y: Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313-2322, 1993
21. Santamaria P, Lewis C, Jessurun J, Sutherland DE, Barbosa JJ: Skewed T-cell receptor usage and junctional heterogeneity among isletitis αβ and γδ T-cells in human IDDM. Diabetes 43:599-606, 1994
22. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, Pujol-Borrell R: Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J Immunol 153:1360-1377, 1994
23. + T-cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56:613-621, 2007
24. Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C: Recognition of HLA class I-restricted β-cell epitopes in type 1 diabetes. Diabetes 55:3068-3074, 2006
25. Panagiotopoulos C, Qin H, Tan R, Verchere CB: Identification of a β-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes 52:2647-2651, 2003
26. Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO: Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102:18425-18430, 2005
27. Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Greenbaum CJ, Pihoker C, Nepom GT: Identification of novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibodypositive relatives. Diabetes 55:3061-3067, 2006
28. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois-Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, Muller S, Choppin J, Boitard C: Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A 102:10581-10586, 2005
29. Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M, DiLorenzo TP, Serreze DV: HLA-A*0201-restricted T cells from "humanized" NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 176:3257-3265, 2006
30. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
31. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113:451-463, 2004
32. Chentoufi AA, Polychronakos C: Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51:1383-1390, 2002
33. Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA: Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435:224-228, 2005
34. Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D, Devendra D, Beilke J, Gianani R, Gill RG, Eisenbarth GS: Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci U S A 100:10376-10381, 2003
35. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS: Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220-223, 2005
36. Wong FS, Karttunen J, Dumont C, Wen L, Visintin I, Pilip IM, Shastri N, Pamer EG, Janeway CA Jr: Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 5:1026-1031, 1999
37. Krishnamurthy B, Dudek NL, McKenzie MD, Purcell AW, Brooks AG, Gellert S, Colman PG, Harrison LC, Lew AM, Thomas HE, Kay TW: Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 116:3258-3265, 2006
38. Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 203:2737-2747, 2006
39. Regner M, Claesson MH, Bregenholt S, Ropke M: An improved method for the detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells. Exp Clin Immunogenet 13:30-35, 1996
40. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol 173:6727-6734, 2004
41. Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM: Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 54:2053-2059, 2005
42. Rammensee H-G, Bachmann J, Stevanovic S: MHC Ligands and Peptide Motifs. Austin, TX, Landes Bioscience, 1997
43. d that stimulates CD8 T cells in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 99:5551-5556, 2002
44. Oehen S, Brduscha-Riem K: Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 161:5338-5346, 1998
45. Ritchie DS, Hermans IF, Lumsden JM, Scanga CB, Roberts JM, Yang J, Kemp RA, Ronchese F: Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J Immunol Methods 246:109-117, 2000
46. Nakayama M, Babaya N, Miao D, Sikora K, Elliott JF, Eisenbarth GS: Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout. J Autoimmun 25:193-198, 2005
47. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C: Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 111:851-857, 2003
48. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD: The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293-297, 1997
49. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289-292, 1997
50. + T cells in diabetic nonobese diabetic mice. J Immunol 176:1637-1644, 2006